(Q41663739)

English

Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: delineation of usage and mode of action

scientific article published on November 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis: delineation of usage and mode of action (English)

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

multiple sclerosis

0 references

experimental autoimmune encephalomyelitis

1 reference

based on heuristic

inferred from title

author name string

Achiron A

1

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

Gilad R

2

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

Margalit R

3

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

Gabbay U

4

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

Sarova-Pinhas I

5

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

Cohen IR

6

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

Melamed E

7

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

Lider O

8

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

Noy S

9

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

Ziv I

10

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

language of work or name

0 references

publication date

1 November 1994

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

57 Suppl

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

57-61

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1016728

6 June 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1016728

6 June 2018

Multiple Sclerosis as a Disease of Immune Regulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1016728

6 June 2018

Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1016728

6 June 2018

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1016728

6 June 2018

Open controlled therapeutic trial of intravenous immune globulin in relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1016728

6 June 2018

T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1016728

6 June 2018

Activated T lymphocytes in patients with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7964856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myelin basic protein-specific T cell clones and experimental allergic encephalomyelitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7964856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon beta augments suppressor cell function in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7964856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.57.SUPPL.57

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

6 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41663739&oldid=1925664407"